Name | Imiquimod maleate |
---|---|
Synonyms |
1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-, (2Z)-2-butenedioate (1:1)
1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine (2Z)-2-butenedioate (1:1) |
Description | Imiquimod maleate is an immune response modifier that acts as a toll-like receptor 7agonist. |
---|---|
Related Catalog | |
Target |
Toll-like receptor 7 |
In Vivo | In animal models, imiquimod stimulates the innate immune response by increasing NK cell activity, activating macrophages to secretecytokines and nitric oxide, and inducing proliferation and differentiation of B lymphocytes. Imiquimod stimulates the innate immune response through induction, synthesis, and release of cytokines, including interferon-a (IFN-α), interleukin (IL)-6, and tumour necrosis factor (TNF)-α[1]. |
References |
[1]. Bilu D, et al. Imiquimod: modes of action. Br J Dermatol. 2003 Nov;149 Suppl 66:5-8. |
Molecular Formula | C18H20N4O4 |
---|---|
Molecular Weight | 356.376 |
Exact Mass | 356.148468 |
Storage condition | 2-8℃ |